Richard Bold is an Oncology physician affiliated with WinnMed. OpenAlex indexes 333 publications with 8,033 citations (h-index 48).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13400 E Shea Blvd
Scottsdale, AZ 852595499
Telephone
480-301-8000Provider last certified this registry record 25 Sept 2023.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20243 payments
- CONMED CorporationProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Nature Communications
2019 - Unplanned Hospitalization Among Individuals With Cancer in the Year After Diagnosis
Journal of Oncology Practice
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Mayank Sardana, MD
WinnMed
Rakesh Suri, MD
WinnMed
Jorge Rakela, MD
WinnMed
Hugo Vargas, MD
WinnMed
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”